AKER BIOMARINE ASA (AKBM.OL)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 100M 200M 300M FY20: 288.6M FY21: 262.1M FY22: 277.2M FY23: 196.3M FY24: 199M FY20 FY21 FY22 FY23 FY24

Gross Profit Annual

0 40M 80M 120M FY20: 109.6M FY21: 88.1M FY22: 114.8M FY23: 72.4M FY24: 69.1M FY20 FY21 FY22 FY23 FY24

Operating Income Annual

-16M -8M 0 8M 16M 24M FY20: 7M FY21: -13.7M FY22: 22.1M FY23: -10.4M FY24: -6.5M FY20 FY21 FY22 FY23 FY24

Net Income Annual

-70M 0 70M 140M 210M FY20: -5.5M FY21: -8M FY22: 10M FY23: -9M FY24: 180.3M FY20 FY21 FY22 FY23 FY24

Cost of Revenue Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Annual

-60M -40M -20M 0 20M 40M 60M FY20: -51M FY21: 2.6M FY22: 15.1M FY23: 47.4M FY24: 12.2M FY20 FY21 FY22 FY23 FY24

Free Cash Flow Annual

-90M -60M -30M 0 30M 60M 90M FY20: -72.7M FY21: -76.1M FY22: -25.4M FY23: 1.5M FY24: -5.2M FY20 FY21 FY22 FY23 FY24

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.